Table 3. Variables related to the presence of excessive daytime sleepiness.

	Excessive daytime sleepiness		Total	p
	Yes	No
Sex	N = 373	N = 150	N = 523
Male	291 (70.8%)	120 (29.2%)	411	0.617
Female	82 (73.2%)	30 (26.8%)	112
Age Group
20–50	82 (72.6%)	31 (27.4%)	113	0.573
50–60	87 (70.7%)	36 (29.3%)	123
60–70	78 (66.7%)	39 (33.3%)	117
70 +	126 (74.1%)	44 (25.9%)	170
Age (Years)
Mean ± SD	61.9 ± 15.1	60.8 ± 14.9	60.8 ± 16.0	0.470
BMI	N = 366	N = 143	N = 509
Normal	29 (56.9%)	22 (43.1%)	51	<0.001
Overweight	80 (61.1%)	51 (38.9%)	131
Obese	181 (75.7%)	58 (24.3%)	239
Morbid Obese	76 (86.4%)	12 (13.6%)	88
Symptoms*
Snoring	300 (74.3%)	104 (25.7%)	404	0.006
Nocturnal choking	161 (70.3%)	68 (29.7%)	229	0.669
Witnessed apnea	51 (64.6%)	28 (35.4%)	79	0.153
Morning headache	85 (71.4%)	34 (28.6%)	119	0.171
Dizziness	54 (78.3%)	15 (21.7%)	69	0.169
Syncope	24 (72.7%)	9 (27.3%)	33	0.842
Leg discomfort at night	58 (85.3%)	10 (14.7%)	68	0.006
Nocturia	71 (78.9%)	19 (21.1%)	90	0.081
Insomnia	99 (80.5%)	24 (19.5%)	123	0.010
	Yes	NO	Total	p
Comorbidities*	N = 373	N = 150	N = 523
Cardiovascular
Coronary artery disease	39 (73.6%)	14 (26.4%)	53	0.683
Myocardial infarction	3 (60.0%)	2 (40.0%)	5	0.568
Stroke	7 (70.0%)	3 (30.0%)	10	0.913
Arrhythmias	48 (87.3%)	7 (12.7%)	55	0.006
Chronic heart failure	19 (70.4%)	8 (29.6%)	27	0.895
Hypertension	206 (75.5%)	67 (24.5%)	273	0.044
Respiratory
Asthma	34 (82.9%)	7 (17.1%)	41	0.087
Chronic obstructive pulmonary disease	45 (81.8%)	10 (18.2%)	55	0.075
Metabolic Disease
Diabetes	80 (72.7%)	30 (27.3%)	110	0.756
Dyslipidemia	174 (71.6%)	69 (28.4%)	243	0.954
Other co-morbidities
Gastroesophageal reflux disorder	164 (73.5%)	59 (26.5%)	223	0.306
Rhino sinusitis	93 (70.5%)	39 (29.5%)	132	0.762
Dysthyroidism	43 (75.4%)	14 (24.6%)	57	0.469
Kidney Disease	25 (75.8%)	8 (24.2%)	33	0.569
Musculoskeletal disorders	30 (78.9%)	8 (21.1%)	38	0.274
Depression	39 (79.6%)	10 (20.4%)	49	0.177